Abstract
During a survey of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in Bulgaria in 2001-2002, three isolates from Sofia (two Escherichia coli, one Klebsiella pneumoniae) showed cefotaxime MICs that were decreased in the presence of clavulanate and were 2-8-fold higher than those of ceftazidime. Resistance was transferred to a sensitive recipient strain of E. coli. Both wild-type and transconjugant strains produced a cefotaxime-hydrolysing beta-lactamase of pI 8.8. Sequencing of the PCR product obtained with oligonucleotide primers binding outside the coding region identified this beta-lactamase as CTX-M-15. To our knowledge, this is the first report of CTX-M-15 in Bulgaria.
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Bulgaria / epidemiology
-
Cefotaxime / pharmacology
-
Drug Resistance, Bacterial
-
Escherichia coli / drug effects
-
Escherichia coli / enzymology
-
Escherichia coli / isolation & purification*
-
Escherichia coli Infections / epidemiology
-
Escherichia coli Infections / microbiology
-
Female
-
Humans
-
Infant
-
Klebsiella Infections / epidemiology
-
Klebsiella Infections / microbiology
-
Klebsiella pneumoniae / drug effects
-
Klebsiella pneumoniae / enzymology
-
Klebsiella pneumoniae / isolation & purification*
-
Male
-
Microbial Sensitivity Tests
-
Middle Aged
-
Polymerase Chain Reaction
-
beta-Lactamases / genetics
-
beta-Lactamases / metabolism*
Substances
-
Anti-Bacterial Agents
-
beta-lactamase CTX-M-15
-
beta-Lactamases
-
Cefotaxime